RF Transseptal Puncture Needles Driving The Minimally Invasive Upgrade Of Cardiac Interventions

https://pmc.ncbi.nlm.nih.gov/articles/PMC4333976/

In recent years, minimally invasive cardiac interventional technology has rapidly proliferated, and clinical demands for surgical safety, accuracy, and minimally invasive degrees continue to rise. The large-scale clinical application of the Manners RF transseptal puncture needle breaks the industry limitations of traditional mechanical puncture technology, driving the standardization, minimally invasive nature, and safety innovation upgrade of domestic transseptal puncture surgeries and even the cardiac intervention industry as a whole.

Traditional TSP surgeries have long been constrained by instrument shortcomings, suffering from three major industry pain points: high technical thresholds, high complication rates, and low success rates for complex cases. In the past, excellent operators needed years of clinical accumulation to skillfully control mechanical puncture force and angle, making it difficult for primary hospitals to carry out complex left-heart interventional surgeries, leading to uneven distribution of high-quality cardiac medical resources. The Manners RF puncture needle replaces mechanical brute force with RF energy, simplifying the puncture operation logic and lowering the surgical learning curve. This enables primary care physicians to accurately complete standardized puncture surgeries, promoting the decentralization of high-quality interventional diagnosis and treatment technology.

At the level of clinical technological innovation, the product overcomes the difficulties of puncturing complex anatomical structures. For clinically high-incidence complex cases such as thickened fossa ovalis, septal fibrosis, atrial septal aneurysm, and postoperative scar adhesions, traditional instruments have high failure rates and great risks. However, precise RF energy puncture can easily penetrate diseased tissue, greatly improving the success rate of surgeries for complex conditions. It expands the diagnostic and therapeutic boundaries of cardiac minimally invasive surgeries, allowing more high-risk and complex heart disease patients to benefit from minimally invasive treatments.

At the industry safety upgrade level, the atraumatic needle tip design, debris-free puncture mode, and controllable RF energy output fundamentally reduce surgical risks such as cardiac tamponade, tissue laceration, thromboembolism, and excessive radiation. This greatly reduces the incidence of postoperative complications, cuts down on patients' secondary treatment costs, and enhances the health economics value of cardiac interventional surgeries. Simultaneously, standardized production processes, unified product parameters, and authoritative international certifications promote the improvement of the standardization system for RF puncture instruments, phasing out backward traditional mechanical puncture devices.

Relying on technical cooperation advantages with top international medical companies, Manners continuously optimizes the process and performance of RF puncture needles, achieving the alignment of domestic precision interventional instruments with international high-end levels. Breaking the monopoly of imported instruments, it provides domestic medical institutions with high-cost-performance, high-quality minimally invasive interventional core instruments, contributing to the high-quality development of China's minimally invasive cardiac intervention industry.